Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Acetyl-DL-Leucine on cerebellar ataxia
DRKS00009733Phase 3Completed
- Sponsor
- LMU Klinikum
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of acetyl-DL-leucine in congenital nonprogressive ataxia (CNPA), cerebellar ataxia (CA), Late-onset cerebellar ataxia (LOCA), Genetic Ataxias, sponsored by LMU Klinikum. Started Jan 2016; status: completed.
02
Drugs
acetyl-DL-leucine
03
Conditions
congenital nonprogressive ataxia (CNPA)cerebellar ataxia (CA)Late-onset cerebellar ataxia (LOCA)Genetic Ataxias
Beyond the preview
Go deeper on DRKS00009733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00009733.